{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:36:54Z","timestamp":1720067814825},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00105-018-4212-8","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T06:53:14Z","timestamp":1528354394000},"page":"1014-1020","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prim\u00e4r kutane Lymphome \u2013 eine Fallserie von 163\u00a0Patienten"],"prefix":"10.1007","volume":"69","author":[{"given":"D.","family":"Nashan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schmitt-Graeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4212_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2340\/00015555-2337","volume":"96","author":"Y Aklund","year":"2016","unstructured":"Aklund Y, Aronsson A, Schmidtchen A, Relander T (2016) Mycosis fungoides: a\u00a0retrospective study of 44 Swedish cases. Acta Derm Venereol 96:669\u2013673","journal-title":"Acta Derm Venereol"},{"key":"4212_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1610-0387.2007.06337.x","volume":"5","author":"C Assaf","year":"2007","unstructured":"Assaf C, Gellrich S, Steinhoff M et\u00a0al (2007) Cutaneous lymphomas in Germany: an analysis of the central cutaneous Lymphoma registry of the German Society of Dermatology (DDG). J\u00a0Dtsch Dermatol Ges 5:662\u2013668","journal-title":"J Dtsch Dermatol Ges"},{"key":"4212_CR3","isbn-type":"print","doi-asserted-by":"publisher","DOI":"10.1002\/9781118492505","volume-title":"Skin lymphoma: the illustrated guide","author":"L Cerroni","year":"2014","unstructured":"Cerroni L (2014) Skin lymphoma: the illustrated guide, 4.\u00a0Aufl. Wiley-Blackwell, Hoboken. ISBN 978-1118492499","ISBN":"http:\/\/id.crossref.org\/isbn\/9781118492499","edition":"4"},{"key":"4212_CR4","unstructured":"Destatis Statistisches Bundesamt (2015) Bev\u00f6lkerung in Deutschland. \n                    https:\/\/www.destatis.de\/bevoelkerungspyramide\/\n                    \n                  . Zugegriffen: 04.04.2018"},{"key":"4212_CR5","first-page":"1266","volume":"15","author":"E Dippel","year":"2017","unstructured":"Dippel E, Assaf C, Becker JC et\u00a0al (2017) S2k guidelines \u2013 cutaneous lymphomas update 2016 \u2013 part 1: classification and diagnosis (ICD10 C82 \u2013 C86). J\u00a0Dtsch Dermatol Ges 15:1266\u20131273","journal-title":"J Dtsch Dermatol Ges"},{"key":"4212_CR6","first-page":"112","volume":"16","author":"E Dippel","year":"2018","unstructured":"Dippel E, Assaf C, Becker JC et al (2018) S2k guidelines \u2013 cutaneous lymphomas update 2016 \u2013 part 2: treatment and follow-up (ICD10 C82 \u2013 C86). J\u00a0Dtsch Dermatol Ges 16:112\u2013122","journal-title":"J Dtsch Dermatol Ges"},{"key":"4212_CR7","first-page":"83","volume-title":"Interdisziplin\u00e4re Leitlinien zur Diagnostik und Behandlung von Hauttumoren","author":"R Dummer","year":"2005","unstructured":"Dummer R, Stadler R, Sterry W (2005) Deutsche Leitlinie: Kutane Lymphome. In: Garbe C (Hrsg) Interdisziplin\u00e4re Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Thieme, Stuttgart, New York, S\u00a083\u201395"},{"key":"4212_CR8","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jdv.12907","volume":"29","author":"J Eder","year":"2015","unstructured":"Eder J, Kern A, Moser J et\u00a0al (2015) Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a\u00a0dermatology referral centre between 2006 and 2013. J\u00a0Eur Acad Dermatol Venereol 29:1517\u20131523","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4212_CR9","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","volume":"33","author":"JT Edinger","year":"2009","unstructured":"Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH (2009) CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol 33:1860\u20131868","journal-title":"Am J Surg Pathol"},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000475634","volume":"40","author":"K Elsayad","year":"2017","unstructured":"Elsayad K, Susek KH, Eich HT (2017) Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T\u2011cell-lymphoma. Oncol Res Treat 40:244\u2013252","journal-title":"Oncol Res Treat"},{"key":"4212_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/bjd.13690","volume":"172","author":"A Fauconneau","year":"2015","unstructured":"Fauconneau A, Pham-Ledard A, Cappellen D et al (2015) Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a\u00a0study of 66 cases. Br J Dermatol 172:1547\u20131554","journal-title":"Br J Dermatol"},{"key":"4212_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/10428190802064925","volume":"49","author":"P Golling","year":"2008","unstructured":"Golling P, Cozzio A, Dummer R, French L, Kempf W (2008) Primary cutaneous B\u2011cell lymphomas \u2013 clinicopathological, prognostic and therapeutic characterization of 54 cases according to the WHO-EORTC classification and the ISCL\/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leuk Lymphoma 49:1094\u20131103","journal-title":"Leuk Lymphoma"},{"key":"4212_CR13","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.17.05670-X","author":"V Grandi","year":"2017","unstructured":"Grandi V, Violetti SA, La Selva R et al (2017) Primary cutaneous B\u2011cell lymphoma. Narrative review of the literature. G\u00a0Ital Dermatol Venereol. \n                    https:\/\/doi.org\/10.23736\/S0392-0488.17.05670-X","journal-title":"G Ital Dermatol Venereol"},{"key":"4212_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07526.x","volume":"156","author":"D Nashan","year":"2007","unstructured":"Nashan D, Faulhaber D, St\u00e4nder S, Luger TA, Stadler R (2007) Mycosis fungoides: a\u00a0dermatological masquerader. Br J Dermatol 156:1\u201310","journal-title":"Br J Dermatol"},{"key":"4212_CR15","first-page":"1207","volume":"14","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, Wobser M (2016) Cutaneous B\u2011cell lymphomas \u2013 pathogenesis, diagnostic workup, and therapy. J\u00a0Dtsch Dermatol Ges 14:1207\u20131225","journal-title":"J Dtsch Dermatol Ges"},{"key":"4212_CR16","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"EA Olsen","year":"2011","unstructured":"Olsen EA, Whittaker S, Kim YH et\u00a0al (2011) Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a\u00a0consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J\u00a0Clin Oncol 29:2598\u20132607","journal-title":"J Clin Oncol"},{"key":"4212_CR17","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2014","unstructured":"R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna (\n                    http:\/\/www.R-project.org\/\n                    \n                  )"},{"key":"4212_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1080\/10428190802136368","volume":"49","author":"MO Riou-Gotta","year":"2008","unstructured":"Riou-Gotta MO, Fournier E, Mermet I et al (2008) Primary cutaneous lymphomas: a\u00a0population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. Leuk Lymphoma 49:1537\u20131544","journal-title":"Leuk Lymphoma"},{"key":"4212_CR19","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH et\u00a0al (2015) Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a\u00a0prognostic model. J\u00a0Clin Oncol 33:3766\u20133777","journal-title":"J Clin Oncol"},{"key":"4212_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","volume":"112","author":"NJ Senff","year":"2008","unstructured":"Senff NJ, Noordijk EM, Kim YH et al (2008) European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B\u2011cell lymphomas. Blood 112:1600\u20131609","journal-title":"Blood"},{"key":"4212_CR21","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2016.06.011","volume":"75","author":"SN Tolkachjov","year":"2016","unstructured":"Tolkachjov SN, Weenig RH, Comfere NI (2016) Cutaneous peripheral T\u2011cell lymphoma, not otherwise specified: a\u00a0single-center prognostic analysis. J\u00a0Am Acad Dermatol 75:992\u2013999","journal-title":"J Am Acad Dermatol"},{"key":"4212_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","volume":"77","author":"F Trautinger","year":"2017","unstructured":"Trautinger F, Eder J, Assaf C et\u00a0al (2017) European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 update 2017. Eur J Cancer 77:57\u201374","journal-title":"Eur J Cancer"},{"key":"4212_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0452-9","volume":"10","author":"E Tse","year":"2017","unstructured":"Tse E, Kwong YL (2017) The diagnosis and management of NK\/T-cell lymphomas. J\u00a0Hematol Oncol 10:1\u201313","journal-title":"J Hematol Oncol"},{"key":"4212_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamadermatol.2016.1597","volume":"152","author":"S Santen van","year":"2016","unstructured":"van Santen S, Roach RE, van Doorn R et\u00a0al (2016) Clinical staging and prognostic factors in folliculotropic mycosis fungoides. Jama Dermatol 152:992\u20131000","journal-title":"Jama Dermatol"},{"key":"4212_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00105-015-3739-1","volume":"67","author":"G Wagner","year":"2016","unstructured":"Wagner G, Rose CH, Meyer V et al (2016) Subkutanes pannikulitisartiges T\u2011Zell-Lymphom. Hautarzt 67:397\u2013402","journal-title":"Hautarzt"},{"key":"4212_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(51)91975-7","volume":"1","author":"AB Wallace","year":"1951","unstructured":"Wallace AB (1951) The exposure treatment of burns. Lancet 1:501\u2013504","journal-title":"Lancet"},{"key":"4212_CR27","first-page":"767","volume":"14","author":"I Wieser","year":"2016","unstructured":"Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M (2016) Primary cutaneous CD30(+) lymphoproliferative disorders. J\u00a0Dtsch Dermatol Ges 14:767\u2013782","journal-title":"J Dtsch Dermatol Ges"},{"key":"4212_CR28","first-page":"515","volume":"147","author":"R Willemze","year":"2012","unstructured":"Willemze R (2012) Thirty years of progress in cutaneous lymphoma research. G\u00a0Ital Dermatol Venereol 147:515\u2013521","journal-title":"G Ital Dermatol Venereol"},{"key":"4212_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.semdp.2016.11.009","volume":"34","author":"R Willemze","year":"2017","unstructured":"Willemze R (2017) Cutaneous lymphomas with a\u00a0panniculitic presentation. Semin Diagn Pathol 34:36\u201343","journal-title":"Semin Diagn Pathol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4212-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4212-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4212-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T23:25:23Z","timestamp":1559863523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4212-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4212-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"7 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Klein erhielt Honorare f\u00fcr redaktionelle T\u00e4tigkeiten und Fahrtkostenzusch\u00fcsse zu wissenschaftlichen Kongressen von der TEVA GmbH. D.\u00a0Nashan, C.M.\u00a0Friedrich, E.\u00a0Geissler, A.\u00a0Schmitt-Graeff und F.\u00a0Meiss geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}